pfizer glp-1 news Liver Injury Ends Development of Pfizer's Oral for Obesity Pfizer Dividend Yield Soars to

Some individuals may experience digestive upset or nausea, especially if taken on an empty stomach

Not FDA-approved for any therapeutic use

It helps bridge the gap between full medical dependence and going it alone, allowing patients to maintain their new weight without the heavy side effects or cost of a full therapeutic dose

doi: 10.3389/fphys.2024.1397280 Received 12 March 2024 Accepted 27 May 2024 Published 24 June 2024 Volume 15 - 2024 Edited by Martin Burtscher, University of Innsbruck, Austria Reviewed by Esteban Ortiz-Prado, University of the Americas, Ecuador Bhuvnesh Kumar, Sharda University, India Updates Copyright 2024 Wang, Chen, Song, Huang and Xiao